Cuba confirms encouraging advances in the lung cancer vaccine

Published at: 10/02/2026 05:30 PM

The Minister of Foreign Affairs of Cuba, Bruno Rodríguez, highlighted through his official channels the advances of the first therapeutic treatment designed to combat lung cancer.

The diplomat assured that the drug has generated positive results, positioning itself as a milestone in the island's biotechnology.

The drug, called Cimavax-EGF, is the result of a strategic alliance between scientists from the Center for Molecular Immunology (CIM) in Cuba and the U.S. institution Roswell Park Comprehensive Cancer Center.

In this regard, the foreign minister said: “Since 2017, our country's Center for Molecular Immunology has been cooperating with the American institution Roswell Park in a clinical trial with this valuable treatment.”

The Cuban diplomat took advantage of the presentation to reflect on the limitations imposed by coercive measures against the island, pointing out that the success of Cimavax-EGF is just a sign of the potential wasted due to political tensions.

“It's an example of how much cooperation could be developed between the two countries in the absence of the blockade and the current criminal policy of economic war against our people,” he said.

With this progress, Cuba reaffirms its scientific sovereignty and its willingness to work together for the benefit of global health, always under a framework of mutual respect and absence of hostility.

Mazo News Team